# World Maternal Antifibrinolytic Trial_2

> **NCT03475342** · PHASE3 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 15068 (actual)

## Conditions studied

- Intrapartum - Moderate and Severe Anaemia

## Interventions

- **DRUG:** Tranexamic Acid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03475342
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-24
- **Primary completion:** 2023-09-20
- **Final completion:** 2023-10-29
- **Target enrollment:** 15068 (ACTUAL)
- **Last updated:** 2024-01-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03475342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03475342, "World Maternal Antifibrinolytic Trial_2". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03475342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*